Proteon Therapeutics, Inc. (PRTO) EPS Estimated At $-0.43

Louis Casey

Investors sentiment increased to 1.14 in Q3 2017. Its up 0.60, from 0.54 in 2017Q2. It improved, as 3 investors ...

PFSweb, Inc. (PFSW) EPS Estimated At $0.13

Nellie Frank

Investors sentiment increased to 0.83 in Q3 2017. Its up 0.12, from 0.71 in 2017Q2. It is positive, as 9 ...

Analysts See $-1.24 EPS for Opiant Pharmaceuticals, Inc. (OPNT)

Clifton Ray

Analysts expect Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) to report $-1.24 EPS on March, 15.They anticipate $6.15 EPS change or 125.25 % ...

$-0.29 EPS Expected for MannKind Corporation (MNKD)

Kurt Siggers

Analysts expect MannKind Corporation (NASDAQ:MNKD) to report $-0.29 EPS on March, 15.They anticipate $0.10 EPS change or 52.63 % from ...

EPS for Seres Therapeutics, Inc. (MCRB) Expected At $-0.73

Hazel Jackson

Analysts expect Seres Therapeutics, Inc. (NASDAQ:MCRB) to report $-0.73 EPS on March, 15.They anticipate $0.10 EPS change or 15.87 % ...

Ladenburg Thalmann Financial Services Inc. (LTS) EPS Estimated At $-0.02

Peter Erickson

Analysts expect Ladenburg Thalmann Financial Services Inc. (NYSEAMERICAN:LTS) to report $-0.02 EPS on March, 15.They anticipate $0.05 EPS change or ...

$-0.02 EPS Expected for Ladenburg Thalmann Financial Services Inc. (LTS)

Dolores Ford

Analysts expect Ladenburg Thalmann Financial Services Inc. (NYSEAMERICAN:LTS) to report $-0.02 EPS on March, 15.They anticipate $0.05 EPS change or ...

Karyopharm Therapeutics Inc. (KPTI) Analysts See $-0.58 EPS

Dolores Ford

Investors sentiment increased to 2.5 in 2017 Q3. Its up 0.94, from 1.56 in 2017Q2. It is positive, as 5 ...

« Previous PageNext Page »